Exploitation of alternative skin models from academia to industry: proposed functional categories to answer needs and regulation demands
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
OPINION article Front. Physiol., 02 June 2023Sec. Skin Physiology Volume 14 - 2023 | https://doi.org/10.3389/fphys.2023.1215266
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The ASM like reconstructed skin, organ on a chip, ex vivo skin, and different computational models hold more promising applications than the animal models (138).”
From The dark side of beauty: an in-depth analysis of the health hazards and toxicological impact of synthetic cosmetics and personal care products (2024) · cites this paper as [138]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The use of alternative skin models (ASM) for testing purposes attracted the attention of both industries and academia. The ASM development is now considered crucial in the field of dermatology as animal models studies are time consuming, costly, react differently compared to human skin, and issues of ethical concerns.”
From The dark side of beauty: an in-depth analysis of the health hazards and toxicological impact of synthetic cosmetics and personal care products (2024) · cites this paper as [138]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human organs-on-chips for disease modelling, drug development and personalized medicine
Ingber, D. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00466-9 · Cited by 1,589 · cited 1×
“For example, the database obtained from models that mimic the skin environment could be used to study skin diseases and develop new treatments, including personalized medicine approaches (Ingber, 2022).”
BackgroundIntrinsic and extrinsic factors in skin ageing: a review
Farage, M. A., Miller, K. W., Elsner, P., & Maibach, H. I. (2008) · International Journal of Cosmetic Science · doi:10.1111/j.1468-2494.2007.00415.x · Cited by 950 · cited 1×
“Models for environmental stressors can be used to prove protection efficacy by comparing damage markers before and after treatment (Farage et al., 2008; Portugal-Cohen et al., 2009).”
BackgroundRegulation (EC) No 764/2008 of the European Parliament and of the Council
Smith, R. (2015) · Core EU Legislation · doi:10.1007/978-1-137-54482-7_19 · Cited by 465 · cited 1×
“In cosmetics, animal testing has been banned in the European Union and several other countries since 2013 (UNION, 2009).”
BackgroundViceconti, M., Pappalardo, F., Rodriguez, B., Horner, M., Bischoff, J., & Musuamba Tshinanu, F. (2021) · Methods · doi:10.1016/j.ymeth.2020.01.011 · Cited by 361 · cited 1×
“In vitro and in silico models have been developed to assess the safety of these chemicals before human testing (Viceconti et al., 2021).”
BackgroundThe use of skin models in drug development
Mathes, S. H., Ruffner, H., & Graf-Hausner, U. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.006 · Cited by 318 · cited 4×
“In the field of dermatology, the development of ASM has become crucial (Mathes et al., 2014; Yun et al., 2018).”
BackgroundInfluentialPumpless microfluidic platform for drug testing on human skin equivalents
Abaci, H. E., Gledhill, K., Guo, Z., Christiano, A. M., & Shuler, M. L. (2015) · Lab on a Chip · doi:10.1039/c4lc00999a · Cited by 262
Yuspa, S. H. (1994) · PubMed · Cited by 255
Niehues, H., Bouwstra, J. A., El Ghalbzouri, A., Brandner, J. M., Zeeuwen, P. L. J. M., & van den Bogaard, E. H. (2018) · Experimental Dermatology · doi:10.1111/exd.13531 · Cited by 210 · cited 2×
“, 2022) systemically acting drugs applied on the skin; (Niehues et al., 2018) drugs acting at the site of application in the case of skin diseases or disorders.”
BackgroundAdvances in the Biofabrication of 3D Skin in vitro: Healthy and Pathological Models
Randall, M. J., Jüngel, A., Rimann, M., & Wuertz-Kozak, K. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00154 · Cited by 194 · cited 1×
“They are created by combining different cell types, such as keratinocytes, fibroblasts, and melanocytes, in a three-dimensional structure; hence, different application types can be tested (Randall et al., 2018).”
BackgroundLimitations of Animal Studies for Predicting Toxicity in Clinical Trials
Van Norman, G. A. (2020) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2020.03.010 · Cited by 186
Research works printed but not linked: 2
- économiques Odcedd (2013). Test No. 439: Vitro skin irritation-reconstructed human epidermis test method (OECD Publishing).
- Lincoln J. E. (2012). Overview of the us fda gmps: Good manufacturing practice (gmp)/quality system (qs) regulation (21 CFR part 820). J. validation Technol. 18 (3), 17.
Cited by
Sanjarnia, P., Picchio, M. L., Solis, A. N. P., Schuhladen, K., Fliss, P. M., Πολιτάκος, Ν., Metterhausen, L., Calderón, M., & Osorio‐Blanco, E. R. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115217 · Cited by 94
Alnuqaydan, A. M. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1439027 · Cited by 84
Advances in regenerative medicine-based approaches for skin regeneration and rejuvenation
Alves, N. S. D., Reigado, G. R., Santos, M., Caldeira, I. D. S., Hernandes, H. D. S., Freitas, B. L., Zhivov, E. V., Chambergo, F. S., & Nunes, V. A. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1527854 · Cited by 71
Bhar, B., Das, E., Manikumar, K., & Mandal, B. B. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303312 · Cited by 47
In vitro 3D skin culture and its sustainability in toxicology: a narrative review
Masri, S., Fauzi, M. B., Rajab, N. F., Lee, W.-H., Zainal Abidin, D. A., & Siew, E. L. (2024) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2024.2407617 · Cited by 15
“…safer products and regulatory decisions aimed at protecting human health. commercial tissue manufacturing standardization, international validation and regulatory approval have led to the widespread usage of 3D reconstructed human skin models in industrial and academic research labs worldwide [62].”
Komarnisky, R.-M., Wootten, S., Friedman, N., & Nikkhah, M. (2025) · Lab on a Chip · doi:10.1039/d5lc00426h · Cited by 17
Sakib, S., Andoy, N. M., Yang, J. Y. C., Galang, A., Sullan, R. M. A., & Zou, S. (2025) · Biomaterials Science · doi:10.1039/d4bm01530d · Cited by 11
Forraz, N., Bize, C., Desroches, A.-L., Milet, C., Payen, P., Chanut, P., Kern, C., Garcia, C., & McGUCKIN, C. P. (2023) · Microorganisms · doi:10.3390/microorganisms11092183 · Cited by 10
Arrom, L. M., Mora, I., & Garrote, L. (2025) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.70341 · Cited by 14
Three-dimensional models of human skin for biomedical applications
Yadav, S., & Nguyen, N. (2025) · Biophysics Reviews · doi:10.1063/5.0251982 · Cited by 11
Brownell, D., Carignan, L., Alavi, R., Caneparo, C., Labroy, M., Galbraith, T., Chabaud, S., Berthod, F., Gibot, L., Bordeleau, F., et al. (2025) · Cells · doi:10.3390/cells14141123 · Cited by 6
“As skin in vitro models are increasingly important to both academia and industry [60], the biochemical analysis focussed on dermal fibroblasts.”
3D bioprinting in regenerative medicine: From skin to organ engineering
Haykal, D., Benhamou, A.-C., Lotti, T., & Duteille, F. (2025) · Annales de Chirurgie Plastique Esthétique · doi:10.1016/j.anplas.2025.06.013 · Cited by 9
Kang, C., Yun, W., & Jeong, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-49844-1 · Cited by 3
Põhako‐Palu, K., Preem, L., Randmäe, K., Putrinš, M., Kingo, K., Tenson, T., & Kogermann, K. (2025) · Wound Repair and Regeneration · doi:10.1111/wrr.70080 · Cited by 3
Cedrola, C. C., Cedrola, C. C., de Paula, A. C. C., da Costa, J. D. C., & Vilela, F. M. P. (2025) · Toxicology in Vitro · doi:10.1016/j.tiv.2025.106187 · Cited by 3
Advancing intradermal vaccine delivery: Focus on hollow microneedles and skin models
Verbist, W., Broeckhoven, E., Vanwersch, P., Choudhari, V. S., Hileghem, L. V., Spasić, D., Coelmont, L., Evens, T., Castagne, S., Bael, A. V., et al. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2619235 · Cited by 3
“102,103 These models not only provide an alternative during preclinical development but also offer tunable and replicable properties across samples, thereby reducing the influence of biological variability inherent to in vivo or ex vivo skin samples, which is crucial during the early stages of…”
Huth, L., Heise, R., Marquardt, Y., Jansen, M., Kluwig, D., Schmidt, M. F., Albuscheit, N., von Felbert, V., CTC-A Translation Group, Jockenhoevel, S., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1661851 · Cited by 1
Toxicology and critical assessment of graphene hydrogels
Patil, N. B., Patil, K. R., Pawar, A. R., More, M. P., Adam, H., & Gopinath, S. C. B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-31448-3.00017-3 · Cited by 1
Shkrigunov, T., Vavilov, N. E., Samenkova, N. F., Kisrieva, Y. S., Rusanov, A. L., Romashin, D. D., Karuzina, I. I., Лисица, А. В., & Petushkova, N. A. (2024) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20247001061 · Cited by 1
Rahmah, M., Al‐Ashwal, R. H., & Salim, M. I. M. (2024) · International Conference on Smart Sensors and Application (ICSSA) · doi:10.1109/icssa62312.2024.10788627
“This has prompted researchers to focus heavily on creating a model that replicates human skin to replace animal testing [1].”
Jang, B. J., Shin, J. A., Oh, J., Lee, J.-D., Yoon, S., Ham, Y., Kim, J. M., & Shin, H. S. (2025) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-025-00219-5
“In particular, the cosmetics industry is increasingly banning animal testing worldwide, leading to extensive research on artificial skin as an alternative test method [12–14].”
Zhang, X. D., Atalla, N. A., Rodriguez, E., Teng, C., Bai, X., & Teng, J. M. C. (2026) · Scientific Reports · doi:10.1038/s41598-026-38877-x
Gomatam, A., Mathew, M., Raj, J. P., Raikuvar, K., Katawale, S., Savla, H. M., Iyer, K., & Coutinho, E. C. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70333
Toral-Orduno, J., Reddy, R. D., & Yusuf, N. (2026) · International Journal of Translational Medicine · doi:10.3390/ijtm6030039
“Integrated benchmarking frameworks and comparative datasets will be increasingly useful for classifying model performance, identifying application-specific strengths, and guiding standardization across different 3D skin platforms [59].”
Influential
Metadata
- Authors
- Portugal-Cohen, M., Cohen, D., Kohen, R., & Oron, M.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2023-06-02
- Volume
- 14
- Pages
- 1215266-1215266
- ISSN
- 1664-042X (ISSN-L)
- PMC
- PMC10272927
- OpenAlex
- W4379231920
- Cited by
- 24
- References
- 57
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 6 · 2023: 2
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Physiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- skin substitutes, skin physiology, functional categories, regulatory requirements, university-industry collaboration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
